These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2570008)

  • 41. Acid secretion and acid suppression in pathogenesis and healing of peptic ulcer disease.
    Thomson AB
    Hepatogastroenterology; 1990 Jul; 37 Suppl 1():18-28. PubMed ID: 1976583
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Inhibition of 24-hour acidity by nizatidine].
    Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
    Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine.
    Reynolds JR; Walt RP; Clark AG; Hardcastle JD; Langman MJ
    Aliment Pharmacol Ther; 1987 Feb; 1(1):23-30. PubMed ID: 2979209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omeprazole in infants with cimetidine-resistant peptic esophagitis.
    Alliët P; Raes M; Bruneel E; Gillis P
    J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
    Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
    Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
    Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
    Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [H2 receptor blockaders: domains for oral use. Indications for cimetidine and ranitidine in gastroenterology].
    Hotz J
    Fortschr Med; 1984 Feb; 102(8):203-4. PubMed ID: 6086477
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of oral famotidine on 24-hour intragastric acidity.
    Santana IA; Lanzon-Miller S; Pounder RE
    Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Famotidine in the USA: a review of efficacy studies.
    Gitnick G
    J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
    Langtry HD; Grant SM; Goa KL
    Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 52. [Histamine H2-receptor antagonists as new anti-ulcer agents].
    Takemoto T
    Nihon Rinsho; 1984 Jan; 42(1):103-13. PubMed ID: 6143835
    [No Abstract]   [Full Text] [Related]  

  • 53. [24-hour intragastric acid profile in a ZES patient with H2 blockers].
    Dammann HG; Müller P; Simon B; Kommerell B
    Z Gastroenterol; 1984 Jun; 22(6):318-20. PubMed ID: 6147052
    [No Abstract]   [Full Text] [Related]  

  • 54. Prolonged gastric pH monitoring in responder and nonresponder duodenal ulcer patients: response to placebo and to H2-blocker administration.
    Masoero G; Rossanino A; Arossa W; De la Pierre M
    J Clin Gastroenterol; 1991 Jun; 13(3):291-5. PubMed ID: 1676715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
    Weiser HF; Gubernatis G; Siewert JR
    Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
    Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
    Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Famotidine versus ranitidine for the short-term treatment of duodenal ulcer.
    Simon B; Dammann HG; Jakob G; Miederer SE; Müller P; Ottenjann R; Paul F; Scholten T; Schütz E; Seifert E
    Digestion; 1985; 32 Suppl 1():32-7. PubMed ID: 2866134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Therapeutic approach in patients with concomitant disease/drug--drug interactions (roxatidine acetate).
    Collins JD
    Scand J Gastroenterol Suppl; 1988; 146():89-99. PubMed ID: 2906472
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?
    Bauerfeind P; Cilluffo T; Fimmel CJ; Emde C; von Ritter C; Kohler W; Gugler R; Gasser T; Blum AL
    Gut; 1987 May; 28(5):549-56. PubMed ID: 3596336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.